WallStSmart

Futu Holdings Ltd (FUTU)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 9589% more annual revenue ($2.33T vs $24.06B). FUTU leads profitability with a 46.2% profit margin vs 17.3%. FUTU trades at a lower P/E of 12.1x. NMR earns a higher WallStSmart Score of 84/100 (A-).

FUTU

Strong Buy

79

out of 100

Grade: B+

Growth: 10.0Profit: 9.0Value: 6.0Quality: 6.5
Piotroski: 5/9Altman Z: 1.33

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FUTU6 strengths · Avg: 9.2/10
Profit MarginProfitability
46.2%10/10

Keeps 46 of every $100 in revenue as profit

Operating MarginProfitability
66.7%10/10

Strong operational efficiency at 66.7%

Revenue GrowthGrowth
35.6%10/10

Revenue surging 35.6% year-over-year

Return on EquityProfitability
28.6%9/10

Every $100 of equity generates 29 in profit

P/E RatioValuation
12.1x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
43.0%8/10

Earnings expanding 43.0% YoY

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

FUTU1 concerns · Avg: 2.0/10
Altman Z-ScoreHealth
1.332/10

Distress zone — elevated risk

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : FUTU

The strongest argument for FUTU centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 46.2% and operating margin at 66.7%. Revenue growth of 35.6% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : FUTU

The primary concerns for FUTU are Altman Z-Score.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

FUTU is growing revenue faster at 35.6% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 79/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Futu Holdings Ltd

FINANCIAL SERVICES · CAPITAL MARKETS · China

Futu Holdings Limited operates an online brokerage and wealth management platform in Hong Kong and internationally. The company is headquartered in Hong Kong, Hong Kong.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?